🇺🇸 FDA
Patent

US 9724387

Administration of growth factors for the treatment of CNS disorders

granted A61KA61K33/242A61K33/244

Quick answer

US patent 9724387 (Administration of growth factors for the treatment of CNS disorders) held by The Regents of the University of California expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K33/242, A61K33/244, A61K38/18, A61K38/185